ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Blood and Biopsy Genomic Signatures of Acute Rejection in Liver Transplant Recipients.

    J. Levitsky,1 T. Whisenant,2 S. Kurian,2 S. Rao,1 A. Demetris,3 M. Abecassis.1

    1Northwestern, Chicago; 2The Scripps Research Institute, San Diego; 3University of Pittsburgh, Pittsburgh

    Background: Biomarker profiles diagnostic of acute rejection (AR) could enhance the diagnosis and management of liver transplant (LT) recipients. Our aim was to identify diagnostic…
  • 2017 American Transplant Congress

    Complement Binding Activity (C3d, C1q) of De Novo Donor-Specific HLA Antibody Is Associated with Increased Risk of Antibody-Mediated Rejection in Non-Sensitized Kidney Transplant Recipients.

    H. Lee,1 E. Han,1 A.-R. Choi,1 K. Park,2 J. Ryu,2 B. Chung,3 C. Yang,3 E.-J. Oh.1

    1Laboratory Medicine, The Catholic University of Korea, Seoul, South Korea (KOR), Korea; 2Biomedical Science, Graduate School, The Catholic University of Korea, Seoul, South Korea (KOR), Korea; 3Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea, Seoul, South Korea (KOR), Korea

    Despite advances in therapeutic strategies and medicine, antibody mediated rejection (AMR) is a leading cause of kidney graft loss. The complement binding activity of donor-specific…
  • 2017 American Transplant Congress

    Comparison Between IgG, C1q and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.

    M. Moreno Gonzales,1 D. Mitema,2 B. Smith,3 C. Schinstock,3 M. Stegall,3 M. Gandhi.3

    1Servicio de Cirugía General, Clínica Anglo Americana, Lima, Peru; 2Division of Nephrology, Mississippi Baptist Medical Center, Jackson, MS; 3Transplant Center, Mayo Clinic, Rochester, MN

    Introduction. Donor specific antibodies (DSA) are associated with an increased risk of chronic antibody mediated rejection (CAMR). DSA characterization by single antigen bead (SAB) assays…
  • 2017 American Transplant Congress

    PTEN Inhibition in MSC Upregulates PD-L1 and Enhances Their Immunomodulatory Capacity Prolonging Skin Allograft Survival.

    M. Climov, M. Uehara, Z. Solhjou, H. Matsumine, N. Bouyani, E. Kefaloyianni, B. Basmani, V. Kasinath, G. Giatsidis, D. Orgill, R. Abdi.

    Brigham and Women's Hospital, Boston, MA

    Due to lack of autologous and donor site morbidity, there is a distinct clinical need to increase the utility of skin allografts by improving their…
  • 2017 American Transplant Congress

    Effect of Induction Therapy in ABO Incompatible Living-Donor Kidney Transplantation: A Single Center Experience.

    L. Lanfranco, L. Esposito, A. Del Bello, O. Cointault, A. Allal, L. Rostaing, N. Kamar.

    Department of Nephrology and Organ Transplantation, Toulouse University Hospital, Toulouse, France

    Due to the shortage in organs, ABO incompatible (ABOi) living-donor kidney transplantation (LDKT) was developed. Herein, we report on our single center experience and assess…
  • 2017 American Transplant Congress

    A New Strategy for Loco-Regional Therapy of Hepatocellular Carcinoma: Stereotactic Body Radiotherapy as a Bridge to Liver Transplantation.

    T. Uemura,1 A. Kirichenko,2 M. Bunker,3 M. Vincent,1 L. Machado,1 A. Singhal,1 N. Thai.1

    1Transplant Surgery, Allegheny General Hospital, Pittsburgh; 2Radiation Oncology, Allegheny General Hospital, Pittsburgh; 3Pathology, Allegheny General Hospital, Pittsburgh

    Background: Transarterial chemoembolization (TACE) or radiofrequency ablation are often used as local Hepatocellular Carcinoma (HCC) treatment while waiting for a liver transplant (LTx). However, it…
  • 2017 American Transplant Congress

    The American Transplant Congress Effect on Kidney Discard Rates in the United States.

    D. Abdelwahab,1 G. Wei,2 I. Hall.2

    1Mayo Clinic, Scottsdale, AZ; 2University of Utah, Salt Lake City, UT

    Background: Deceased-donor kidneys with high kidney donor risk index (KDRI) are often discarded despite evidence that certain candidates would have better survival accepting these kidneys…
  • 2017 American Transplant Congress

    KDPI Usefulness in Spain: A Comparison with Classical ECD/SCD.

    C. Arias-Cabrales,1 M. Pérez-Sáez,1 D. Redondo,1 A. Buxeda,1 C. Burballa,1 S. Bermejo,1 A. Sierra,1 M. Mir,1 A. Burón,2 A. Zapatero,3 M. Crespo,1 J. Pascual.1

    1Nephrology, Hospital del Mar, Barcelona, Spain; 2Epidemiology and Evaluation, Hospital del Mar, Barcelona, Spain; 3Intensive Care Medicine, Hospital del Mar, Barcelona, Spain

    Kidney donor shortage requires an expansion in selection criteria and objective tools to minimize discarded organs. Easy donor pretx variables such as age, standard/expanded criteria…
  • 2017 American Transplant Congress

    Identification of NKG2D as Senescence Marker in Zero-Hour Kidney Biopsies Is Indicative for Clinical Outcome.

    T. Resch,1 J. Günther,1 H. Hackl,2 A. Sattler,3 S. Ebner,1 P. Ritschl,3 M. Biebl,3 R. Öllinger,3 S. Schneeberger,1 G. Brandacher,4 H. Schwelberger,1 B. Zelger,5 D. Stauch,3 A. Pascher,3 J. Pratschke,3 K. Kotsch.3

    1Center of Operative Medicine, Department for Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria; 2Division of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria; 3Department for General, Visceral and Transplantation Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany; 4Department of Plastic and Reconstructive Surgery, Vascularized Composite Allotransplantation Laboratory, John Hopkins University School of Medicine, Baltimore; 5Institute of Pathology, Medical University of Innsbruck, Innsbruck, Austria

    The definition of biological donor organ age rather than chronological age seems an obvious factor for the establishment of valid pre-transplant risk assessment. We therefore…
  • 2017 American Transplant Congress

    Kidney-Specific Immunosuppression without Adverse Systemic Effects.

    D. Kentrup,1 K. Schuette-Nuetgen,1 H. Pawelski,1 H. Pavenstädt,1 S. Hermann,2 M. Schaefers,2 G. Larbig,3 A. Kuebelbeck,3 S. Reuter.1

    1Department of Medicine D, University Hospital Muenster, Muenster, Germany; 2European Institute for Molecular Imaging - EIMI, University Hospital Muenster, Muenster, Germany; 3Merck KGaA, Darmstadt, Germany

    Purpose: Immunosuppressive therapy is often accompanied by severe adverse effects. To overcome this, the aim of this study was the evaluation of a kidney-specific drug…
  • « Previous Page
  • 1
  • …
  • 133
  • 134
  • 135
  • 136
  • 137
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences